Using two independent quantitative approaches Fulci et al. [137] demonstrated an impressive over expression of miR-21 in leukemic CD19+ cells of B-CLL patients, with a 3.8 fold to a maximum of 10-fold increase compared to normal CD19 cells. The gene discussed is CD19; the disease is B-cell chronic lymphocytic leukemia.